Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2021-08-13 AGM Information
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Resolutions from Extraordinary General Meeting of Elos Medtech AB (publ) 2021
AGM Information Classification · 95% confidence The document explicitly details the resolutions passed during an 'Extraordinary General Meeting (EGM)' concerning the number of board members, their fees, and the election/dismissal of directors. This content directly relates to shareholder governance and meeting outcomes. While it is not the formal 'Declaration of Voting Results' (DVA), the core subject matter—decisions made at a general meeting—is most closely aligned with governance and meeting materials. Since the document details the *results* and *decisions* of the meeting itself, and not just a proxy solicitation (PSI) or a general board change announcement (MANG), the most appropriate classification is AGM-R, as EGMs often share similar documentation structures with AGMs regarding resolutions and board composition changes, or DVA if the focus was purely on the vote tally. Given the focus on electing/dismissing board members and setting fees based on EGM resolutions, AGM-R (AGM Information, which often serves as a proxy for EGM resolution summaries) or DVA (Declaration of Voting Results) are the closest fits. Since it details the *resolutions* passed, DVA is slightly more precise for voting outcomes, but AGM-R covers the general meeting context. Given the context of board changes and fee setting, which are typical AGM topics, AGM-R is selected as the best fit for summarizing the meeting's decisions.
2021-08-13 English
Kommuniké från extra bolagsstämma i Elos Medtech AB (publ) 2021
AGM Information Classification · 98% confidence The document is titled "Kommuniké från extra bolagsstämma i Elos Medtech AB (publ) 2021" which translates to "Communiqué from the Extraordinary General Meeting in Elos Medtech AB (publ) 2021". It details decisions made regarding the number of board members, board remuneration, and the election/dismissal of board members during this extraordinary general meeting (EGM). This content directly relates to shareholder meetings and the resulting decisions, which falls under the scope of AGM Information (AGM-R), even though it is an EGM, as it concerns meeting outcomes and governance structure changes resulting from a shareholder vote. The document explicitly states the decisions made at the meeting.
2021-08-13 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage for The Goldman Sachs Group, Inc. in Elos Medtech AB, specifically noting a 'Reason for major shareholding notification Sell' and providing the 'Before the transaction' and 'After the transaction' share quantities and percentages. This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The relevant code is MRQ.
2021-07-19 English
Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ)
AGM Information Classification · 98% confidence The document is explicitly titled "Notice to attend the Extraordinary General Meeting of Elos Medtech AB (publ)" and details the date, procedures (advance voting due to Covid-19), agenda items (including election of Chairman, Board members, and fees), and proposals for decisions to be voted upon at the EGM. This content directly relates to the formal process and materials surrounding a shareholder meeting, specifically an Extraordinary General Meeting (EGM). While it is a notice, the core purpose is to convene the meeting and present the items for shareholder vote, which aligns most closely with the purpose of an AGM/EGM notice, which is covered by the AGM-R code, or potentially PSI if it were a proxy statement, but the focus here is the meeting notice itself. Given the options, AGM-R (AGM Information) is the best fit for materials related to a General Meeting, even if it is an Extraordinary one.
2021-07-16 English
Kallelse till extra bolagsstämma i Elos Medtech AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till extra bolagsstämma i Elos Medtech AB (publ)" which translates to "Notice of Extraordinary General Meeting in Elos Medtech AB (publ)". It details the date, procedures (specifically for advance voting due to COVID-19), the agenda (including election of chairman, board members, and remuneration), and proposals for shareholder votes. This content is characteristic of a formal notice calling for a shareholder meeting, which is closely related to the materials distributed to solicit votes. The closest matching category is 'Proxy Solicitation & Information Statement' (PSI), as it contains the necessary information and proposals for shareholders to vote on, even though it is specifically a 'Notice' (Kallelse). It is not a DEF 14A (Remuneration Report) or a DVA (Declaration of Voting Results), but the document soliciting the vote itself. Given the options, PSI is the most appropriate fit for a notice containing voting proposals for a general meeting.
2021-07-16 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for Q2 2021, which provides comprehensive financial statements, key performance indicators (KPIs), management commentary, and analysis of business segments (Dental, Orthopedics, Life Science). It contains substantive financial data for the period, distinguishing it from a mere announcement or summary. Therefore, it is classified as an Interim/Quarterly Report. Q2 2021
2021-07-16 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.